BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35057098)

  • 1. Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers.
    Ioniţă S; Lincu D; Mitran RA; Ziko L; Sedky NK; Deaconu M; Brezoiu AM; Matei C; Berger D
    Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of tamoxifen loaded silica and NH2 functionalized mesoporous silica nanoparticles as delivery systems against MCF-7 breast cancer cells.
    Taghavi S; Shahnani M; Rafati H
    Iran J Basic Med Sci; 2023; 26(11):1334-1341. PubMed ID: 37885996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol.
    Summerlin N; Qu Z; Pujara N; Sheng Y; Jambhrunkar S; McGuckin M; Popat A
    Colloids Surf B Biointerfaces; 2016 Aug; 144():1-7. PubMed ID: 27060664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate.
    Esperanza Adrover M; Pedernera M; Bonne M; Lebeau B; Bucalá V; Gallo L
    Saudi Pharm J; 2020 Jan; 28(1):15-24. PubMed ID: 31920429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
    Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of [Ru(η
    Edeler D; Arlt S; Petković V; Ludwig G; Drača D; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
    J Inorg Biochem; 2018 Mar; 180():155-162. PubMed ID: 29288894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy.
    Chaudhary Z; Subramaniam S; Khan GM; Abeer MM; Qu Z; Janjua T; Kumeria T; Batra J; Popat A
    Front Bioeng Biotechnol; 2019; 7():225. PubMed ID: 31620434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles.
    Juère E; Florek J; Bouchoucha M; Jambhrunkar S; Wong KY; Popat A; Kleitz F
    Mol Pharm; 2017 Dec; 14(12):4431-4441. PubMed ID: 29094948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adsorption and Release Properties of Drug Delivery System Naproxen-SBA-15: Effect of Surface Polarity, Sodium/Acid Drug Form and
    Zauška Ľ; Beňová E; Urbanová M; Brus J; Zeleňák V; Hornebecq V; Almáši M
    J Funct Biomater; 2022 Dec; 13(4):. PubMed ID: 36547535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonic Acid Derivative-Modified SBA-15, PHTS and MCM-41 Mesoporous Silicas as Carriers for a New Antiplatelet Drug: Ticagrelor Adsorption and Release Studies.
    Moritz M; Geszke-Moritz M
    Materials (Basel); 2020 Jun; 13(13):. PubMed ID: 32610486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antioxidant and Anti-Inflammatory Properties of Wild Bilberry Fruit Extracts Embedded in Mesoporous Silica-Type Supports: A Stability Study.
    Brezoiu AM; Deaconu M; Mitran RA; Sedky NK; Schiets F; Marote P; Voicu IS; Matei C; Ziko L; Berger D
    Antioxidants (Basel); 2024 Feb; 13(2):. PubMed ID: 38397847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Nanoconfinement of Polyphenolic Extract from Grape Pomace into Functionalized Mesoporous Silica on Its Biocompatibility and Radical Scavenging Activity.
    Brezoiu AM; Bajenaru L; Berger D; Mitran RA; Deaconu M; Lincu D; Stoica Guzun A; Matei C; Moisescu MG; Negreanu-Pirjol T
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32756379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
    Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
    J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
    Dening TJ; Taylor LS
    Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Mercaptothiazoline modified mesoporous silica for mercury removal from aqueous media.
    Pérez-Quintanilla D; del Hierro I; Fajardo M; Sierra I
    J Hazard Mater; 2006 Jun; 134(1-3):245-56. PubMed ID: 16326000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of Mesoporous Silica Supports in Aqueous Solutions: Implications for Mesoporous Silica-based Water Treatment Processes.
    Pham AL; Sedlak DL; Doyle FM
    Appl Catal B; 2012 Sep; 126():258-264. PubMed ID: 23055573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.